Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets
Abstract Influenza viruses cause annual seasonal epidemics and sporadic pandemics; vaccination is the most effective countermeasure. Intranasal live attenuated influenza vaccines (LAIVs) are needle-free, mimic the natural route of infection, and elicit robust immunity. However, some LAIVs require re...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b30473452fc54337aa97734a70ab5f16 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:b30473452fc54337aa97734a70ab5f16 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b30473452fc54337aa97734a70ab5f162021-12-02T13:39:34ZIntranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets10.1038/s41541-021-00320-92059-0105https://doaj.org/article/b30473452fc54337aa97734a70ab5f162021-04-01T00:00:00Zhttps://doi.org/10.1038/s41541-021-00320-9https://doaj.org/toc/2059-0105Abstract Influenza viruses cause annual seasonal epidemics and sporadic pandemics; vaccination is the most effective countermeasure. Intranasal live attenuated influenza vaccines (LAIVs) are needle-free, mimic the natural route of infection, and elicit robust immunity. However, some LAIVs require reconstitution and cold-chain requirements restrict storage and distribution of all influenza vaccines. We generated a dry-powder, thermostable LAIV (T-LAIV) using Preservation by Vaporization technology and assessed the stability, immunogenicity, and efficacy of T-LAIV alone or combined with delta inulin adjuvant (Advax™) in ferrets. Stability assays demonstrated minimal loss of T-LAIV titer when stored at 25 °C for 1 year. Vaccination of ferrets with T-LAIV alone or with delta inulin adjuvant elicited mucosal antibody and robust serum HI responses in ferrets, and was protective against homologous challenge. These results suggest that the Preservation by Vaporization-generated dry-powder vaccines could be distributed without refrigeration and administered without reconstitution or injection. Given these significant advantages for vaccine distribution and delivery, further research is warranted.Jasmina M. LuczoTatiana BousseScott K. JohnsonCheryl A. JonesNicholas PearceCarlie A. NeiswangerMin-Xuan WangErin A. MillerNikolai PetrovskyDavid E. WentworthVictor BronshteinMark PapaniaStephen M. TompkinsNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 6, Iss 1, Pp 1-8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Jasmina M. Luczo Tatiana Bousse Scott K. Johnson Cheryl A. Jones Nicholas Pearce Carlie A. Neiswanger Min-Xuan Wang Erin A. Miller Nikolai Petrovsky David E. Wentworth Victor Bronshtein Mark Papania Stephen M. Tompkins Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets |
description |
Abstract Influenza viruses cause annual seasonal epidemics and sporadic pandemics; vaccination is the most effective countermeasure. Intranasal live attenuated influenza vaccines (LAIVs) are needle-free, mimic the natural route of infection, and elicit robust immunity. However, some LAIVs require reconstitution and cold-chain requirements restrict storage and distribution of all influenza vaccines. We generated a dry-powder, thermostable LAIV (T-LAIV) using Preservation by Vaporization technology and assessed the stability, immunogenicity, and efficacy of T-LAIV alone or combined with delta inulin adjuvant (Advax™) in ferrets. Stability assays demonstrated minimal loss of T-LAIV titer when stored at 25 °C for 1 year. Vaccination of ferrets with T-LAIV alone or with delta inulin adjuvant elicited mucosal antibody and robust serum HI responses in ferrets, and was protective against homologous challenge. These results suggest that the Preservation by Vaporization-generated dry-powder vaccines could be distributed without refrigeration and administered without reconstitution or injection. Given these significant advantages for vaccine distribution and delivery, further research is warranted. |
format |
article |
author |
Jasmina M. Luczo Tatiana Bousse Scott K. Johnson Cheryl A. Jones Nicholas Pearce Carlie A. Neiswanger Min-Xuan Wang Erin A. Miller Nikolai Petrovsky David E. Wentworth Victor Bronshtein Mark Papania Stephen M. Tompkins |
author_facet |
Jasmina M. Luczo Tatiana Bousse Scott K. Johnson Cheryl A. Jones Nicholas Pearce Carlie A. Neiswanger Min-Xuan Wang Erin A. Miller Nikolai Petrovsky David E. Wentworth Victor Bronshtein Mark Papania Stephen M. Tompkins |
author_sort |
Jasmina M. Luczo |
title |
Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets |
title_short |
Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets |
title_full |
Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets |
title_fullStr |
Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets |
title_full_unstemmed |
Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets |
title_sort |
intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/b30473452fc54337aa97734a70ab5f16 |
work_keys_str_mv |
AT jasminamluczo intranasalpowderliveattenuatedinfluenzavaccineisthermostableimmunogenicandprotectiveagainsthomologouschallengeinferrets AT tatianabousse intranasalpowderliveattenuatedinfluenzavaccineisthermostableimmunogenicandprotectiveagainsthomologouschallengeinferrets AT scottkjohnson intranasalpowderliveattenuatedinfluenzavaccineisthermostableimmunogenicandprotectiveagainsthomologouschallengeinferrets AT cherylajones intranasalpowderliveattenuatedinfluenzavaccineisthermostableimmunogenicandprotectiveagainsthomologouschallengeinferrets AT nicholaspearce intranasalpowderliveattenuatedinfluenzavaccineisthermostableimmunogenicandprotectiveagainsthomologouschallengeinferrets AT carlieaneiswanger intranasalpowderliveattenuatedinfluenzavaccineisthermostableimmunogenicandprotectiveagainsthomologouschallengeinferrets AT minxuanwang intranasalpowderliveattenuatedinfluenzavaccineisthermostableimmunogenicandprotectiveagainsthomologouschallengeinferrets AT erinamiller intranasalpowderliveattenuatedinfluenzavaccineisthermostableimmunogenicandprotectiveagainsthomologouschallengeinferrets AT nikolaipetrovsky intranasalpowderliveattenuatedinfluenzavaccineisthermostableimmunogenicandprotectiveagainsthomologouschallengeinferrets AT davidewentworth intranasalpowderliveattenuatedinfluenzavaccineisthermostableimmunogenicandprotectiveagainsthomologouschallengeinferrets AT victorbronshtein intranasalpowderliveattenuatedinfluenzavaccineisthermostableimmunogenicandprotectiveagainsthomologouschallengeinferrets AT markpapania intranasalpowderliveattenuatedinfluenzavaccineisthermostableimmunogenicandprotectiveagainsthomologouschallengeinferrets AT stephenmtompkins intranasalpowderliveattenuatedinfluenzavaccineisthermostableimmunogenicandprotectiveagainsthomologouschallengeinferrets |
_version_ |
1718392639583158272 |